REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE

NCT01369407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-09-07

No results posted yet for this study

Summary

REVIVAL will establish a prospective, observational, multicenter patient cohort in ambulatory patients with chronic, advanced, systolic heart failure that will provide a greater understanding of their clinical trajectory (rates of hospitalizations, transplantation, MCSD use and death), and of how baseline clinical risk measures are related to prognosis.

Conditions

  • Congestive Heart Failure

Interventions

OTHER

No Intervention

Not an interventional study

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Brigham and Women's Hospital

    collaborator OTHER
  • University of Michigan

    lead OTHER

Principal Investigators

  • Keith Aaronson, MD, MS · University of Michigan

  • Garrick Stewart, MD · Brigham and Women's Hospital

  • Doug Mann, MD · University of Washington - St. Louis

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2018-08-29
Completion
2018-08-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01369407 on ClinicalTrials.gov